Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

The melanocortin system.

Ira Gantz¹, Tung M Fong

¹Department of Surgery, University of Michigan Medical School, Ann Arbor, Michigan 48109-0682, USA. Igantz@Umich.edu

American Journal of Physiology. Endocrinology and Metabolism

|January 31, 2003

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Association of Ertugliflozin on Kidney Outcomes in People After and Without an Interval Cardiovascular Event: Observations From the VERTIS CV Trial.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

Same author

Negligible Rebound in Myopia Progression Following Cessation of Treatment with 0.01% Atropine for 3 years: Year-4 Results from the CHAMP Phase 3 Clinical Trial.

Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)·2026

Same author

Post-authorization safety study to assess the risk of diabetic ketoacidosis among type 2 diabetes mellitus patients treated with ertugliflozin compared to patients treated with other antihyperglycaemic agents in a Medicare and Medicaid population.

Diabetic medicine : a journal of the British Diabetic Association·2026

Same author

Cardiovascular and Renal Outcomes with Ertugliflozin by Baseline Use of Renin-Angiotensin-Aldosterone System Inhibitors or Diuretics, Including Mineralocorticoid Receptor Antagonist: Analyses from the VERTIS CV Trial.

Kidney diseases (Basel, Switzerland)·2025

Same author

Clinical Trial: A Phase 2b Study to Evaluate the Efficacy and Safety of MK-3655 in Individuals With Pre-Cirrhotic MASH.

Alimentary pharmacology & therapeutics·2025

Same author

Heart failure outcomes captured by adverse event reporting in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the VERTIS CV trial.

European journal of heart failure·2025

Same journal

Low oxygen availability induces a metabolic shift towards enhanced glucose utilization in non-lipid-loaded and lipid-loaded HepG2 cells.

American journal of physiology. Endocrinology and metabolism·2026

Same journal

Obesity-Related Circulating Endothelial Extracellular Vesicles Negatively Affect Cerebral Microvascular Cell Function.

American journal of physiology. Endocrinology and metabolism·2026

Same journal

Nitrate and resveratrol supplementation selectively enhances hepatic adaptations to aerobic exercise in high-fat fed male mice.

American journal of physiology. Endocrinology and metabolism·2026

Same journal

Chemogenetic placental activation and proteomic extracellular vesicle signatures predict functional roles across pregnancy and postpartum.

American journal of physiology. Endocrinology and metabolism·2026

Same journal

Branched chain and glucogenic amino acids predict brown fat recruitment and metabolic clearance in adults with overweight or obesity.

American journal of physiology. Endocrinology and metabolism·2026

Same journal

Gut Microbiota-Generated Trimethylamine <i>N</i>-Oxide from Dietary Choline and Glucose Homeostasis in Humans.

American journal of physiology. Endocrinology and metabolism·2026

See all related articles

The melanocortin system, involving peptides and receptors, plays key roles in pigmentation, inflammation, energy, and sexual function. Further research into selective agonists and antagonists may lead to new therapies.

Area of Science:

Endocrinology and Metabolism
Neuroscience
Pharmacology

Background:

The melanocortin system is a complex network involving peptides derived from the proopiomelanocortin gene, five melanocortin receptors, endogenous antagonists, and ancillary proteins.
Understanding the melanocortin system is crucial for various physiological processes.

Purpose of the Study:

To provide an abbreviated account of the basic biochemistry, pharmacology, and physiology of the melanocortin system.
To highlight recent progress in understanding the roles of melanocortins.
To explore the potential for new pharmacotherapies targeting this system.

Main Methods:

Review of recent pharmacological and genetic studies.
Analysis of the components of the melanocortin system: peptides, receptors, antagonists, and ancillary proteins.

Related Experiment Videos

Main Results:

Pharmacological and genetic studies confirm the involvement of melanocortins in pigmentation.
Melanocortins are implicated in regulating inflammation.
The system plays a significant role in energy homeostasis and sexual function.

Conclusions:

Selective agonists and antagonists are valuable tools for investigating melanocortin system functions.
Further research is expected to provide an experimental basis for developing novel pharmacotherapies.
The melanocortin system represents a promising target for therapeutic interventions.